PET/CT Scan as a Tool to Rationalize the Treatment of Patients With

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03594448` - Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients
Completed	`NCT03986541` - AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer
Completed	`NCT01570452` - Matrilysin Expression in Different Stages of Colorectal Tumors	N/A
Recruiting	`NCT05354817` - Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin	Phase 2
Recruiting	`NCT05576896` - Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory	Phase 2
Completed	`NCT04715061` - Impact of Aerobic Exercise on Immune Response and Side Effects of Cancer Treatments	N/A
Terminated	`NCT03149679` - The p53 Colorectal Cancer Trial	Phase 2
Completed	`NCT05550701` - Prognostic Impact of Increased Lymph Node Yield in Colorectal Cancer Patients With Synchronous Distant Metastasis: a Population-based Study of the US Database and a Chinese Registry
Enrolling by invitation	`NCT04149613` - Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer
Completed	`NCT04425239` - Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer	Phase 2
Completed	`NCT06329700` - Parenchymal Sparing Hepatectomy in Post-chemotherapy Liver Atrophy
Recruiting	`NCT05382741` - Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial	Phase 2
Recruiting	`NCT06342440` - Early Detection of Advanced Adenomas and Colorectal Cancer
Not yet recruiting	`NCT04917276` - Treatment Response Prediction System of mCRC Patients Based on CTC
Not yet recruiting	`NCT06296056` - Phase I Study of Combined Immune Cell Therapy in Patients With Stage 4 Colorectal Cancer With Metastatic Lesion Who Failed Prior Standard of Care	Phase 1
Recruiting	`NCT04714814` - Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
Not yet recruiting	`NCT05451719` - Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy	Phase 2
Completed	`NCT03031444` - Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis	Phase 2/Phase 3
Completed	`NCT05164419` - Impact de la Marge de résection Sur la Survie à Long Terme et le Taux de récidive Des Patients Atteints de Cancers Colorectaux opérés au CHUS Entre 2006 et 2016 Pour Des métastases hépatiques
Recruiting	`NCT05171660` - Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer	Phase 3

NCT number	NCT02618850
Study type	Interventional
Source	National Cancer Institute, Naples
Contact
Status	Active, not recruiting
Phase	N/A
Start date	April 2014
Completion date	December 2024

PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment — PETRA2 - CRC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms